What clinical trials are currently recruiting in Rhode Island?

TrialFinder lists 489 recruiting clinical trials with sites in or near Rhode Island. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in Rhode Island?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in Rhode Island?

Trials in Rhode Island cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in Rhode Island?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

489 Recruiting Trials

Clinical Trials in Rhode Island

Browse 489 recruiting clinical trials currently enrolling participants in Rhode Island. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 489 recruiting trials in Rhode Island

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

N/A Athens, Alabama +4 sites · Lumbar Spinal Stenosis

Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

PHASE3 Anchorage, Alaska +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

PHASE2 Birmingham, Alabama +4 sites · Extensive Stage Lung Small Cell Carcinoma

Recruiting

Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma

PHASE1 Los Angeles, California +4 sites · Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Recruiting

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

PHASE4 Birmingham, Alabama +4 sites · Peripartum Cardiomyopathy, Postpartum

Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy

Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

PHASE2 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

PHASE3 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8

Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

PHASE3 Birmingham, Alabama +4 sites · Neuroblastoma, Ganglioneuroblastoma, Nodular

Recruiting

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

PHASE2 Little Rock, Arkansas +4 sites · Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8

Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia

Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

PHASE3 Birmingham, Alabama +4 sites · Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features

Recruiting

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

PHASE3 Huntsville, Alabama +4 sites · Kidney Disease, Chronic

Recruiting

See all 489 results in Rhode Island

Check Your Eligibility

Create a free profile and our AI will match you to trials in Rhode Island you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in Rhode Island

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon